Actively Recruiting
Study of BW-50218 in Healthy Participants
Led by Shanghai Argo Biopharmaceutical Co., Ltd. · Updated on 2026-04-13
60
Participants Needed
2
Research Sites
67 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Phase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants
CONDITIONS
Official Title
Study of BW-50218 in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to provide written informed consent and follow study procedures for the whole study
- Body weight and BMI within ranges suitable for study participation as determined by the investigator
- Female participants must be non-pregnant, not breastfeeding, and either unable to have children or using highly effective contraception
- Male participants with partners able to have children must agree to use effective contraception
You will not qualify if you...
- Any medical condition, recent illness, or lab result that may increase risk or interfere with study participation as judged by the investigator
- Recent hospitalization or significant acute medical event
- History of cancer or any long-term medical condition considered clinically relevant by the study doctor
- Clinically significant abnormal lab results at screening or Day -1
- Positive test for hepatitis B, hepatitis C, or HIV
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, Australia, 5000
Actively Recruiting
2
Linear Early Fhase Limited
Nedlands, Western Australia, Australia, 6009
Not Yet Recruiting
Research Team
Z
Zhi Hua
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here